Showing results (1081-1090 of 1,767) with videos related to
Sort By:
Pageof 177
Metabolic Syndrome and Related Disorders|February 8, 2018
Association Between Carotid Intima Media Thickness, Age, and Cardiovascular Risk Factors in Children and AdolescentsVasu D Gooty, Alan R Sinaiko, Justin R Ryder, et al.Journal of Community Hospital Internal Medicine Perspectives|October 20, 2022
POCUS in Internal Medicine Curriculum: Quest for the Holy-Grail of Modern MedicineDevyani Ramgobin, Vasu Gupta, Rea Mittal, et al.IET Nanobiotechnology|May 4, 2019
Gold nanoparticles decorated reduced graphene oxide nanolabel for voltammetric immunosensingVidhu Sara Vargis, Chandhana Jayachandran Priya, Harsha Surendran, et al.Laryngoscope Investigative Otolaryngology|October 20, 2021
Timing of postoperative oral feeding after head and neck mucosal free flap reconstructionJoshua Stramiello, Brian Nuyen, Anirudh Saraswathula, et al.The Journal of Clinical Investigation|March 24, 2015
NOTCH reprograms mitochondrial metabolism for proinflammatory macrophage activationJun Xu, Feng Chi, Tongsheng Guo, et al.ACS Omega|March 27, 2023
Exploring the Phytochemical Profile and Biological Activities of Clerodendrum infortunatumBalakrishnan Syamala Akhil, Rajimol Puthenpurackal Ravi, Asha Lekshmi, et al.Microorganisms|September 27, 2025
Metabolism of Terephthalic Acid by a Novel Bacterial Consortium Produces Valuable By-ProductsMitchell Read Slobodian, Dominique Jillings, Aditya Kishor Barot, et al.Dental and Medical Problems|December 14, 2021
Influence of orthodontic brackets and permanent retainers on the diagnostic image quality of MRI scans: A preliminary studyPraveen Kumar Neela, Venkat Kishan Tatikonda, Mohammed Wahajuddin Syed, et al.International Journal of Radiation Oncology, Biology, Physics|July 17, 2012
AZD5438, an inhibitor of Cdk1, 2, and 9, enhances the radiosensitivity of non-small cell lung carcinoma cellsPavithra Raghavan, Vasu Tumati, Lan Yu, et al.Bioorganic & Medicinal Chemistry|March 26, 2010
Design, synthesis and evaluation of novel 2-thiophen-5-yl-3H-quinazolin-4-one analogues as inhibitors of transcription factors NF-kappaB and AP-1 mediated transcriptional activation: Their possible utilization as anti-inflammatory and anti-cancer agentsRajan S Giri, Hardik M Thaker, Tony Giordano, et al.Pageof 177